Mona Sabharwal

Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?

Sierra Cheng, Erica McDonald, Matthew C. Cheung et al. · Journal of Clinical Oncology · 2017 · 62 citations

An Evaluation Framework for Funding Drugs for Rare Diseases

Eric Winquist, Chaim M. Bell, Joe T.R. Clarke et al. · Value in Health · 2012 · 54 citations

Funding Drugs, Medicine, Pharmacoeconomics +5

The effect of pharmacist education on asthma treatment plans for simulated patients

Lisa Dolovich, Mona Sabharwal, Karen Agro et al. · Pharmacy World & Science · 2007 · 38 citations

Asthma, Allergy, Allergy Medicine +7

Informing Canada’s Cancer Drug Funding Decisions with Scientific Evidence and Patient Perspectives: The Pan-Canadian Oncology Drug Review

Jeffrey S. Hoch, Mona Sabharwal · Current Oncology · 2013 · 35 citations · Full text

Provincial Payers, Preclinical Therapeutics, Translational Medicine +15

Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control

Dean A. Regier, Colene Bentley, Craig Mitton et al. · Social Science & Medicine · 2014 · 28 citations

Medical Decision Making, Public Policy, Clinical Decision-making +9